Low RASSF10 and high MYC or high VEGF was significantly associated with poor prognosis of renal papillary cell cancer patients and the combination of two markers had a higher impact on impaired probability of survival compared with the low RASSF10 alone (Figs. 5e and 6). This evidence concerns the gene RASSF10 and papillary renal cell carcinoma.